Home  »  News   »  MaxCyte Inc. (MXCT): Are the Stars Lining Up for I...

MaxCyte Inc. (MXCT): Are the Stars Lining Up for Investors?

MaxCyte Inc. (MXCT) is priced at $6.23 after the most recent trading session. At the very opening of the session, the stock price was $5.53 and reached a high price of $6.45, prior to closing the session it reached the value of $5.70. The stock touched a low price of $5.53.Recently in News on September 7, 2022, MaxCyte to Participate in Morgan Stanley 20th Annual Global Healthcare Conference. MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization, today announced Company management will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13th at 4:40 p.m. Eastern Time. You can read further details here

MaxCyte Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $10.88 on 01/03/22, with the lowest value was $3.36 for the same time period, recorded on 06/16/22.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


MaxCyte Inc. (MXCT) full year performance was -54.56%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, MaxCyte Inc. shares are logging -58.47% during the 52-week period from high price, and 85.42% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.36 and $15.00.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1271630 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the MaxCyte Inc. (MXCT) recorded performance in the market was -38.86%, having the revenues showcasing 59.34% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 691.72M, as it employees total of 65 workers.

Specialists analysis on MaxCyte Inc. (MXCT)

During the last month, 0 analysts gave the MaxCyte Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 5.09, with a change in the price was noted +0.56. In a similar fashion, MaxCyte Inc. posted a movement of +9.88% for the period of last 100 days, recording 529,731 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for MXCT is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Trends and Technical analysis: MaxCyte Inc. (MXCT)

Raw Stochastic average of MaxCyte Inc. in the period of last 50 days is set at 78.18%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 71.76%. In the last 20 days, the company’s Stochastic %K was 45.88% and its Stochastic %D was recorded 44.58%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -38.86%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -6.60%, alongside a downfall of -54.56% for the period of the last 12 months. The shares increased approximately by 0.16% in the 7-day charts and went down by 10.85% in the period of the last 30 days. Common stock shares were driven by 59.34% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts